HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?

ABSTRACT Background - The increase in the survival following the introduction of highly active antiretroviral therapy (HAART) has seen the emergence of hepatitis C virus (HCV) infection, renal and cardiovascular diseases as important morbidity and mortality causes together with HIV. Objective - The present study aimed to investigate the differences between HIV/hepatitis C virus coinfected and HIV-monoinfected regarding demographic and clinical aspects from a HIV/AIDS clinic in Porto Alegre, Brazil. Methods - Review of medical records of 1,030 HIV infected individuals aged 18 years or more in an urban HIV/AIDS clinic based in Porto Alegre, Southern Brazil. Clinical and demographical Data were collected from the records of the patients attended between March 2008 and December 2012. Results - The present study is a cross-sectional study among HIV-infected patients attended at a public HIV/AIDS clinic in Porto Alegre, Brazil. The prevalence of hepatitis C virus in the present study cohort was 11.8% (CI 95%: 9.9%-13.8%). Hypertension and pathological proteinuria were more common in the coinfected compared to monoinfected group. By the other hand, dyslipidemia were more common among monoinfected patients. There was no difference between the groups regarding CD4+ count or HIV-RNA. Variables significant in the univariate analysis with P<0.05 were further analyzed using a Poisson regression model with robust variance. Coinfected were likely to be older, with lower lipid levels and higher prevalence of pathological proteinuria compared to HIV-monoinfected patients. Although coinfected patients had higher prevalence of tenofovir-based regimen, there was a strong association between hepatitis C virus individuals to pathological proteinuria and dyslipidemia. Conclusion - Clinicians should recognize that coinfected and monoinfected individuals are different groups regarding the traditional and HIV-related risk factors and should be managed and screened individually in order to prevent cardiovascular and renal complications.

Saved in:
Bibliographic Details
Main Authors: ANTONELLO,Vicente Sperb, ANTONELLO,Ivan Carlos Ferreira, ZALTRON,Rosana Ferrazza, TOVO,Cristiane Valle
Format: Digital revista
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE. 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032016000300180
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-28032016000300180
record_format ojs
spelling oai:scielo:S0004-280320160003001802016-09-27HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?ANTONELLO,Vicente SperbANTONELLO,Ivan Carlos FerreiraZALTRON,Rosana FerrazzaTOVO,Cristiane Valle AIDS-related opportunistic infections Hepacivirus Coinfection Highly active antiretroviral therapy ABSTRACT Background - The increase in the survival following the introduction of highly active antiretroviral therapy (HAART) has seen the emergence of hepatitis C virus (HCV) infection, renal and cardiovascular diseases as important morbidity and mortality causes together with HIV. Objective - The present study aimed to investigate the differences between HIV/hepatitis C virus coinfected and HIV-monoinfected regarding demographic and clinical aspects from a HIV/AIDS clinic in Porto Alegre, Brazil. Methods - Review of medical records of 1,030 HIV infected individuals aged 18 years or more in an urban HIV/AIDS clinic based in Porto Alegre, Southern Brazil. Clinical and demographical Data were collected from the records of the patients attended between March 2008 and December 2012. Results - The present study is a cross-sectional study among HIV-infected patients attended at a public HIV/AIDS clinic in Porto Alegre, Brazil. The prevalence of hepatitis C virus in the present study cohort was 11.8% (CI 95%: 9.9%-13.8%). Hypertension and pathological proteinuria were more common in the coinfected compared to monoinfected group. By the other hand, dyslipidemia were more common among monoinfected patients. There was no difference between the groups regarding CD4+ count or HIV-RNA. Variables significant in the univariate analysis with P<0.05 were further analyzed using a Poisson regression model with robust variance. Coinfected were likely to be older, with lower lipid levels and higher prevalence of pathological proteinuria compared to HIV-monoinfected patients. Although coinfected patients had higher prevalence of tenofovir-based regimen, there was a strong association between hepatitis C virus individuals to pathological proteinuria and dyslipidemia. Conclusion - Clinicians should recognize that coinfected and monoinfected individuals are different groups regarding the traditional and HIV-related risk factors and should be managed and screened individually in order to prevent cardiovascular and renal complications.info:eu-repo/semantics/openAccessInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE. Arquivos de Gastroenterologia v.53 n.3 20162016-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032016000300180en10.1590/S0004-28032016000300011
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author ANTONELLO,Vicente Sperb
ANTONELLO,Ivan Carlos Ferreira
ZALTRON,Rosana Ferrazza
TOVO,Cristiane Valle
spellingShingle ANTONELLO,Vicente Sperb
ANTONELLO,Ivan Carlos Ferreira
ZALTRON,Rosana Ferrazza
TOVO,Cristiane Valle
HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?
author_facet ANTONELLO,Vicente Sperb
ANTONELLO,Ivan Carlos Ferreira
ZALTRON,Rosana Ferrazza
TOVO,Cristiane Valle
author_sort ANTONELLO,Vicente Sperb
title HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?
title_short HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?
title_full HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?
title_fullStr HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?
title_full_unstemmed HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?
title_sort hiv and hepatitis c virus coinfection. who is this patient today?
description ABSTRACT Background - The increase in the survival following the introduction of highly active antiretroviral therapy (HAART) has seen the emergence of hepatitis C virus (HCV) infection, renal and cardiovascular diseases as important morbidity and mortality causes together with HIV. Objective - The present study aimed to investigate the differences between HIV/hepatitis C virus coinfected and HIV-monoinfected regarding demographic and clinical aspects from a HIV/AIDS clinic in Porto Alegre, Brazil. Methods - Review of medical records of 1,030 HIV infected individuals aged 18 years or more in an urban HIV/AIDS clinic based in Porto Alegre, Southern Brazil. Clinical and demographical Data were collected from the records of the patients attended between March 2008 and December 2012. Results - The present study is a cross-sectional study among HIV-infected patients attended at a public HIV/AIDS clinic in Porto Alegre, Brazil. The prevalence of hepatitis C virus in the present study cohort was 11.8% (CI 95%: 9.9%-13.8%). Hypertension and pathological proteinuria were more common in the coinfected compared to monoinfected group. By the other hand, dyslipidemia were more common among monoinfected patients. There was no difference between the groups regarding CD4+ count or HIV-RNA. Variables significant in the univariate analysis with P<0.05 were further analyzed using a Poisson regression model with robust variance. Coinfected were likely to be older, with lower lipid levels and higher prevalence of pathological proteinuria compared to HIV-monoinfected patients. Although coinfected patients had higher prevalence of tenofovir-based regimen, there was a strong association between hepatitis C virus individuals to pathological proteinuria and dyslipidemia. Conclusion - Clinicians should recognize that coinfected and monoinfected individuals are different groups regarding the traditional and HIV-related risk factors and should be managed and screened individually in order to prevent cardiovascular and renal complications.
publisher Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE.
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032016000300180
work_keys_str_mv AT antonellovicentesperb hivandhepatitiscviruscoinfectionwhoisthispatienttoday
AT antonelloivancarlosferreira hivandhepatitiscviruscoinfectionwhoisthispatienttoday
AT zaltronrosanaferrazza hivandhepatitiscviruscoinfectionwhoisthispatienttoday
AT tovocristianevalle hivandhepatitiscviruscoinfectionwhoisthispatienttoday
_version_ 1756373531450408960